نتائج البحث - "Mennitto A."

1

دورية أكاديمية

Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial

المؤلفون: Mennitto, A, Verzoni, E, Cognetti, F, Miceli, R, Milella, M, Mosca, A, Chiuri, V E, Bearz, A, Morelli, F, Ortega, C, Atzori, F, Donini, M, Claps, M, Guadalupi, V, Sepe, P, Cappelletti, V, de Braud, F G, Procopio, G

المساهمون: Mennitto, A, Verzoni, E, Cognetti, F, Miceli, R, Milella, M, Mosca, A, Chiuri, V E, Bearz, A, Morelli, F, Ortega, C, Atzori, F, Donini, M, Claps, M, Guadalupi, V, Sepe, P, Cappelletti, V, de Braud, F G, Procopio, G

مصطلحات موضوعية: Metastatic renal cell carcinoma, adjuvant treatment, relapse-free survival, sorafenib, surgical metastasectomy, targeted therapy, Antineoplastic Agents, Carcinoma, Renal Cell, Disease-Free Survival, Follow-Up Studies, Humans, Kidney Neoplasms, Metastasectomy, Neoplasm Recurrence, Local, Probability

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33472450; info:eu-repo/semantics/altIdentifier/wos/WOS:000613363500001; volume:14; issue:2; firstpage:261; lastpage:268; numberofpages:8; journal:EXPERT REVIEW OF CLINICAL PHARMACOLOGY; http://hdl.handle.net/11562/1063756Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100181589

الإتاحة: https://doi.org/10.1080/17512433.2021.1879639Test
http://hdl.handle.net/11562/1063756Test

View record in BASE

2

Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma

المؤلفون: Sarah Scagliarini, Michele Prisciandaro, Roberto Sabbatini, Giorgia Peverelli, Roberto Iacovelli, Giuseppe Procopio, Alessia Mennitto, Salvatore Caponnetto, Gaetano Facchini, Claudia Caserta, Giuseppe Fornarini, Elena Verzoni, Francesco Massari, Ugo De Giorgi, Raffaele Ratta

المصدر: American Journal of Clinical Oncology. 42:42-45

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d34b7bd47a4ac39592d86a1c21e4adcTest
https://doi.org/10.1097/coc.0000000000000478Test

3

Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial

المؤلفون: Franco Morelli, Francesco Atzori, Melanie Claps, Maddalena Donini, Alessandra Mosca, Vera Cappelletti, Alessandra Bearz, Rosalba Miceli, Elena Verzoni, Cinzia Ortega, Francesco Cognetti, M. Milella, Valentina Guadalupi, Pierangela Sepe, V.E. Chiuri, Alessia Mennitto, F. de Braud, Giuseppe Procopio

مصطلحات موضوعية: Sorafenib, Oncology, medicine.medical_specialty, relapse-free survival, medicine.medical_treatment, Cell, Metastatic renal cell carcinoma, adjuvant treatment, Antineoplastic Agents, urologic and male genital diseases, 030226 pharmacology & pharmacy, Relapse free survival, Disease-Free Survival, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, surgical metastasectomy, Medicine, Humans, Pharmacology (medical), In patient, General Pharmacology, Toxicology and Pharmaceutics, Carcinoma, Renal Cell, Probability, business.industry, Carcinoma, Metastasectomy, Renal Cell, General Medicine, medicine.disease, targeted therapy, Kidney Neoplasms, medicine.anatomical_structure, Neoplasm Recurrence, Local, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, business, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c32b2f4c30474e2235fb342aa61cd1a5Test
http://hdl.handle.net/11562/1063756Test

4

دورية أكاديمية

Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program

المؤلفون: Prisciandaro M., Ratta R., Massari F., Fornarini G., Caponnetto S., Iacovelli R., De Giorgi U., Facchini G., Scagliarini S., Sabbatini R., Caserta C., Peverelli G., Mennitto A., Verzoni E., Procopio G.

المساهمون: Prisciandaro, M., Ratta, R., Massari, F., Fornarini, G., Caponnetto, S., Iacovelli, R., De Giorgi, U., Facchini, G., Scagliarini, S., Sabbatini, R., Caserta, C., Peverelli, G., Mennitto, A., Verzoni, E., Procopio, G.

مصطلحات موضوعية: c-Met, cabozantinib, nonclear cell, renal cell carcinoma, targeted therapy, Administration, Oral, Aged, Anilide, Carcinoma, Renal Cell, Disease-Free Survival, Female, Human, Kidney Neoplasm, Male, Middle Aged, Pyridine, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30204614; info:eu-repo/semantics/altIdentifier/wos/WOS:000458278300008; volume:42; issue:1; firstpage:42; lastpage:45; numberofpages:4; journal:AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS; http://hdl.handle.net/11573/1341170Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85058886805

الإتاحة: https://doi.org/10.1097/COC.0000000000000478Test
http://hdl.handle.net/11573/1341170Test

View record in BASE

5

Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases

المؤلفون: Vincenzo Mazzaferro, Massimo Milione, Ilaria Bossi, Alessia Mennitto, Jorgelina Coppa, Federica Perrone, Marta Caporale, Filippo de Braud, Emilio Bajetta, Maria Di Bartolomeo, Christian Cotsoglou, Roberto Iacovelli, Filippo Pietrantonio, Rosa Berenato, Federica Morano, Mauro Scotti, Francesca Ricchini, Alessandra Alessi, Marta Vaiani

المصدر: Clinical Colorectal Cancer. 16:e191-e198

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Organoplatinum Compounds, Colorectal cancer, medicine.medical_treatment, Population, Cetuximab, Kaplan-Meier Estimate, Adenocarcinoma, Irinotecan, Gastroenterology, Disease-Free Survival, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Aged, education.field_of_study, business.industry, Liver Neoplasms, Middle Aged, medicine.disease, Oxaliplatin, Regimen, 030104 developmental biology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Camptothecin, Female, Neoplasm Recurrence, Local, Hepatectomy, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d3f49188abd34093f55e315030b79aTest
https://doi.org/10.1016/j.clcc.2016.09.007Test

6

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

المؤلفون: Elena Verzoni, Giuseppina Calareso, Paolo Grassi, Michele Prisciandaro, Filippo de Braud, Raffaele Ratta, Luca Porcu, Giuseppe Procopio, Alessia Mennitto

المصدر: Drugs in R&D

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Indazoles, Urology, Angiogenesis Inhibitors, Disease-Free Survival, Pazopanib, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Original Research Article, Neoplasm Metastasis, Carcinoma, Renal Cell, Dose Modification, Proportional Hazards Models, Retrospective Studies, Pharmacology, Sulfonamides, Performance status, Dose-Response Relationship, Drug, business.industry, Standard treatment, Hazard ratio, Middle Aged, medicine.disease, Kidney Neoplasms, Discontinuation, 030104 developmental biology, Pyrimidines, Treatment Outcome, 030220 oncology & carcinogenesis, Toxicity, Female, business, Progressive disease, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5b2b90e3123393a4a7f62d5d66dde2Test
http://europepmc.org/articles/PMC5629143Test

7

Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer

المؤلفون: Daniele Rossini, Alessia Mennitto, Martin D. Berger, Sabina Murgioni, Satoshi Okazaki, Wu Zhang, Yuji Miyamoto, Afsaneh Barzi, Marta Schirripa, Shu Cao, H. J. Lenz, Mitsukuni Suenaga, Roel Gopez, D. Y. Yang, Toshiharu Yamaguchi, Yan Ning, Fotios Loupakis, Federica Marmorino

المصدر: Annals of Oncology. 28:1015-1022

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Pyrrolidines, Pyridines, Colorectal cancer, Antineoplastic Agents, Single-nucleotide polymorphism, Disease-Free Survival, Trifluridine, 03 medical and health sciences, 0302 clinical medicine, XRCC3, Internal medicine, medicine, Humans, Progression-free survival, CHEK1, Uracil, 610 Medicine & health, CHEK2, Genetic Association Studies, Aged, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, business.industry, Phenylurea Compounds, Liver Neoplasms, Retrospective cohort study, Original Articles, Hematology, Middle Aged, medicine.disease, Drug Combinations, DNA Repair Enzymes, Treatment Outcome, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cohort, Female, Colorectal Neoplasms, business, Thymine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d6c605f4a9a0ff0b1313f82acf0b96Test
https://doi.org/10.1093/annonc/mdx035Test

8

دورية أكاديمية

Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram

المؤلفون: Pietrantonio, F, Miceli, R, Rimassa, L, Lonardi, S, Aprile, G, Mennitto, A, Marmorino, F, Bozzarelli, S, Antonuzzo, L, Tamburini, E, Morano, F, Rossini, D, Battaglin, F, Baretti, M, Berenato, R, Formica, V, Mosconi, S, Petrelli, F, Ghidini, M, Loupakis, F, Spada, D, Cinieri, S, Beretta, G, Falcone, A, de Braud, F, Cremolini, C

المساهمون: F. Pietrantonio, R. Miceli, L. Rimassa, S. Lonardi, G. Aprile, A. Mennitto, F. Marmorino, S. Bozzarelli, L. Antonuzzo, E. Tamburini, F. Morano, D. Rossini, F. Battaglin, M. Baretti, R. Berenato, V. Formica, S. Mosconi, F. Petrelli, M. Ghidini, F. Loupaki, D. Spada, S. Cinieri, G. Beretta, A. Falcone, F. de Braud, C. Cremolini

مصطلحات موضوعية: TAS-102, colorectal cancer, nomogram, prognosi, refractory, regorafenib, aged, colon, colorectal neoplasm, disease-free survival, drug combination, female, human, logistic model, male, middle aged, neoplasm metastasi, phenylurea compound, proportional hazards model, pyridine, trifluridine, uracil, cost-benefit analysi, nomograms, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27864220; info:eu-repo/semantics/altIdentifier/wos/WOS:000397300100020; volume:28; issue:3; firstpage:555; lastpage:561; numberofpages:7; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/553673Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85018307237

الإتاحة: https://doi.org/10.1093/annonc/mdw627Test
http://hdl.handle.net/2434/553673Test

View record in BASE

9

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

المؤلفون: Claudia Maggi, Gabriella Mariani, Claudio Vernieri, Licia Rivoltini, B Ferrari, Monica Milano, Maria Silvia Cona, Michele Prisciandaro, Veronica Huber, Giulia Bianchi, Filippo de Braud, Alessia Mennitto, Giuseppe Capri, Siranoush Manoukian, Lucia Rinaldi

المصدر: Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, medicine.medical_specialty, Paclitaxel, Neutrophils, medicine.medical_treatment, lcsh:Medicine, Triple Negative Breast Neoplasms, Deoxycytidine, Article, Disease-Free Survival, Carboplatin, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Humans, Lymphocyte Count, Lymphocytes, Progression-free survival, Neoplasm Metastasis, lcsh:Science, Prospective cohort study, Survival rate, Triple-negative breast cancer, Aged, Retrospective Studies, Chemotherapy, Multidisciplinary, business.industry, lcsh:R, Retrospective cohort study, Middle Aged, medicine.disease, Gemcitabine, Metastatic breast cancer, Survival Rate, body regions, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, lcsh:Q, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c4c3e19eb16aa350bbfbd0dda8f611Test
https://doi.org/10.1038/s41598-018-27075-zTest

10

دورية أكاديمية

Single-agent panitumumab in frail elderly patients with advanced RAS and BRAF wild-type colorectal cancer: Challenging drug label to light up new hope

المساهمون: Pietrantonio, Filippo, Cremolini, Chiara, Aprile, Giuseppe, Lonardi, Sara, Orlandi, Armando, Mennitto, Alessia, Berenato, Rosa, Antonio, Carlotta, Casagrande, Mariaelena, Marsico, Valentina, Marmorino, Federica, Cardellino, Giovanni Gerardo, Bergamo, Francesca, Tomasello, Gianluca, Formica, Vincenzo, Longarini, Raffaella, Giommoni, Elisa, Caporale, Marta, Di Bartolomeo, Maria, Loupakis, Fotio, De Braud, Filippo

مصطلحات موضوعية: Elderly, Frail, Metastatic colorectal cancer, Panitumumab, Aged, 80 and over, Antibodies, Monoclonal, Colorectal Neoplasm, Disease-Free Survival, Drug Labeling, Female, Frail Elderly, Human, Kaplan-Meier Estimate, Male, Neoplasm Metastasi, Proto-Oncogene Proteins B-raf, Receptor, Epidermal Growth Factor, ras Protein, Oncology, Cancer Research

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26446234; info:eu-repo/semantics/altIdentifier/wos/WOS:000366043600008; volume:20; issue:11; firstpage:1261; lastpage:1265; numberofpages:5; journal:THE ONCOLOGIST; http://hdl.handle.net/11568/851855Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84946557379; http://theoncologist.alphamedpress.org/content/20/11/1261.full.pdfTest

الإتاحة: https://doi.org/10.1634/theoncologist.2015-0171Test
http://hdl.handle.net/11568/851855Test
http://theoncologist.alphamedpress.org/content/20/11/1261.full.pdfTest

View record in BASE

تنقيح النتائج